SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-025304
Filing Date
2018-04-18
Accepted
2018-04-18 12:57:11
Documents
2
Period of Report
2018-04-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1585
2 POA DOCUMENT poa.txt EX-24.3_784203 2983
  Complete submission text file 0001209191-18-025304.txt   5930
Mailing Address C/O IONIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address
Boyce Sarah (Reporting) CIK: 0001629383 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38137 | Film No.: 18760741

Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Issuer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1